ArticleIndian journal of anaesthesia2025
Modulating AMPA receptor-dependent synaptic plasticity: Mechanistic interventions against remifentanil-induced hyperalgesia in reoperative rats - A randomised controlled trial.
Article in Indian journal of anaesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Intraoperative remifentanil can induce postoperative hyperalgesia. In clinical practice, either unplanned or planned second operations may occur within a short period. However, the impact of remifentanil during this process remains unclear. This study aimed to investigate the pain threshold following two incisional operations under remifentanil analgesia and to examine the contribution of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR). Methods: Experimental rats received remifentanil infusion combined with plantar incision. This dual intervention was repeated twice, separated by a 7-day interval. After completing both treatment cycles, mechanical paw withdrawal thresholds (PWTs) and thermal withdrawal latencies (PWLs) were assessed. Simultaneously, C-fibre evoked field potentials were recorded in parallel with dendritic spine morphology analysis. Additionally, the intrathecal administration of 1-naphthylacetyl spermine trihydrochloride (NASPM) was used to investigate the role of the AMPAR. Results: In rats with two incisions and remifentanil infusions, the second treatment led to lower minimum PWT and PWL values than the first. Compared to controls, these rats exhibited a significantly greater increase in the C-fibre-evoked field potential, as well as in the number of primary branches and spines of spinal dorsal horn neurons. The AMPAR inhibitor NASPM attenuated remifentanil-induced exacerbation of reoperative hyperalgesia, reversed remifentanil-enhanced spinal long-term potentiation, and mitigated the associated morphological changes. Conclusion: Repetitive remifentanil administration during consecutive operations within a short temporal window significantly potentiated opioid-induced hyperalgesia in a rat reoperation model. This hyperalgesic priming was mechanistically associated with upregulated trafficking of spinal AMPARs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.